EVALUATION OF PHARMACISTS’ INTERVENTION ON HEMODIALYSIS PATIENTS RECEIVING INTRAVENOUS AMIKACIN
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: TSENG, Wan-Ting (China Taiwan)
- Co-author(s): Wan-Ting Tseng: Department of Pharmacy, Shin Kong Wu Ho-Su Memorial Hospital, Taipei
During November 2016 to January 2018, patients on regular hemodialysis were observed with critical values of amikacin in regular therapeutic drug monitoring (TDM).
Based on The Stanford Guide Antimicrobial Therapy and the Infectious Diseases Society of America(IDSA) guideline, the local guideline in our hospital to keep.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.